美時化學製藥股份有限公司 (1795)
Total Capital
4,000,000,000
Paid-in Capital
2,700,352,570
Stock Listing Information
Monthly Revenue Info
Price Chart TWSE:1795
Chart by TradingView. Quotes may be delayed; for reference only, not investment advice. TradingView
財務報表與股價評價
收盤價 (2026-11-17)
126.00
-2.00
本益比
15.11
股價淨值比
1.35
殖利率
2.14%
損益表(累計,單位:新臺幣)
財報為年初至該季累計數字;每次僅能取得最新一期,歷史期間隨本站更新逐步累積。
資產負債(115 年 Q1~Q3)
總資產
1,111.3 億
總負債
862.7 億
權益總額
248.6 億
負債比率 / 流動比率
77.6% / 133%
每股淨值
93.30 元
股利政策
資料來源:臺灣證券交易所、證券櫃檯買賣中心、公開資訊觀測站;僅供參考,不構成投資建議。查看全部上市櫃財報排行
Registration Info
Representative
Vilhelm Robert Wessman
Address
臺北市信義區松仁路277號17樓
MapRegistration Date
1966/6/30
Last Update Date
2026/10/8
Business Items
MOEA Registered Items
MOF Tax Items
Business & Equity Network Graph
Links generated by name matching. Scroll to zoom. Click blue/purple nodes to view details.
Directors & Supervisors
| Title | Name | Shares Held | Representative For |
|---|---|---|---|
| 董事長 | Vilhelm Robert Wessman | 0 | |
| 董事 | Petar Antonov Vazharov | 82,754,337 | 0 香港商 Alvogen Emerging Markets Holdings Limited |
| 董事 | Arni Hardarson | 0 | |
| 董事 | Nat Ativitavas | 17,745,191 | 0 Innobic LL Holding Company Limted (股東名簿記載之戶名為美商摩根大通銀行台北分行受託保管INNOBIC有限責任控股公司投資專戶) |
| 董事 | Orakul Suebsiri | 17,745,191 | 0 Innobic LL Holding Company Limted (股東名簿記載之戶名為美商摩根大通銀行台北分行受託保管INNOBIC有限責任控股公司投資專戶) |
| 董事 | Krisana Winitthumkul | 17,745,191 | 0 Innobic LL Holding Company Limted (股東名簿記載之戶名為美商摩根大通銀行台北分行受託保管INNOBIC有限責任控股公司投資專戶) |
| 董事 | Oranee Tangphao Daniels | 0 | |
| 董事 | Yves Hermes | 0 | |
| 獨立董事 | 楊郁民 | 0 | |
| 獨立董事 | Karl Alexius Tiger Karlsson | 0 | |
| 獨立董事 | 王傳芬 | 0 |
Managers
| Title | Name | Onboard Date |
|---|---|---|
| No public manager data available. | ||
Equity Status
Equity Status
-
Foreign Investment
-
Foreign Company Name
-
Multiple Voting Preferred Shares
-
Veto Power Preferred Shares
-
Price Per Share (NTD)
-
Total Issued Shares
-
Registration Status
核准設立
Restrictions on Preferred Shareholders
-